LAPIX
Developer of immunotherapies for immunological diseases
📍 Boston, United States · Immunology
Funding snapshot
Last roundSeries A
Amount$2M
Date21 July 2025
About
Developer of immunotherapies for immunological diseases. It offers a lead candidate LPX-TI641 for multiple sclerosis, Neuromyelitis Optica, Rheumatology, LPX-TIIBD for Inflammatory bowel disease, and also provides gene therapy.
Latest news
No articles yet.
Similar startups
NovaHealth AI
Clinical documentation copilot for ambulatory care networks in the US.
Statiq
Manufacturer of electric vehicle charging hardware and operator of networks
Spyne.ai
Platform offering AI-powered imaging for vehicle photography
Immuneel
Developer of T-cell therapies for the treatment of cancer